Undisclosed AND-Body Programs
Multiple across Lung, Gut, Skin, Bone, Joints, Immune & Circulating Cells
PreclinicalActive
Key Facts
Indication
Multiple across Lung, Gut, Skin, Bone, Joints, Immune & Circulating Cells
Phase
Preclinical
Status
Active
Company
About Ampersand Biomedicines
Ampersand Biomedicines is a Flagship Pioneering-founded biotech developing a novel class of targeted therapeutics called AND-Body Therapeutics. Its proprietary AND Platform combines a computational 'Address Map' of human biology with modular engineering to create drugs that localize to diseased tissue and activate a therapeutic payload only there. The company is in the preclinical stage, targeting a broad range of diseases across multiple organs with its versatile platform technology.
View full company profile